Bringing Out the Usual – and Unusual – Cancer Genomics Suspects
Tuesday, June 18, 2013
Several years ago, researchers sequencing lung cancer genomes encountered a number of red herrings.
Proteome Sciences to Develop Cancer Pathway Profiling Assays
Monday, June 17, 2013
New MS3 TMT® mass spectrometry technique to determine relative quantitation of proteins in multiple samples simultaneously.
Perfinity and Thermo Fisher Scientific Sign Co-Marketing Agreement
Friday, June 14, 2013
The agreement will see the companies co-market an automated protein sample preparation and analysis system.
DNA-Altering Enzyme is Essential for Blood Cell Development
Wednesday, June 12, 2013
The expression of specific genes is partially dictated by the way the DNA is packed into chromatin, a tightly packed combination of DNA and proteins known as histones.
DNA Sequencing Reveals Mucosal Melanoma's Bullseye
Wednesday, June 12, 2013
Scientists have found a molecular 'bullseye' for a rare form of melanoma, opening up opportunities for new targeted treatment.
Exiqon and Asuragen Sign Agreement for Real-Time PCR Services
Tuesday, June 11, 2013
The Service Center Agreement allows Asuragen to provide real-time PCR services based on Exiqon’s miRCURY LNA™ Universal RT microRNA PCR products.
ExpreS2ion Biotechnologies and Cancer Research UK Enter a Licensing Agreement
Tuesday, June 11, 2013
ExpreS2ion Biotechnologies will provide the Cancer Research UK with access to its Drosophila Schneider-2 cell-based technology platform for protein production.
Studies Illuminate Functions of RNA
Tuesday, June 11, 2013
Researchers at the University of California illuminate the functional importance of a relatively new class of RNA molecules.
QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Companion Diagnostics
Monday, June 10, 2013
Several lymphoma-related biomarkers, including EZH2 Y641 gene mutations, rights acquired from British Columbia Cancer Agency.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 4179 |
|
|
